This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
How does Commiphora wightii work to lower cholesterol?
Commiphora wightii, commonly known as guggul, works primarily through its active compounds, guggulsterones Z and E. These compounds act as antagonists to the farnesoid X receptor (FXR), a key regulator of cholesterol and bile acid metabolism. By blocking this receptor, guggul helps increase the conversion of cholesterol into bile acids and promotes its excretion from the body. While this mechanism is well-documented in pharmacological research, clinical evidence (Level C) regarding its efficacy in humans remains mixed compared to conventional statin therapy.
Does guggul interact with thyroid medication?
Yes, Commiphora wightii has significant interactions with thyroid medications. Guggul may stimulate thyroid function, potentially altering thyroid hormone levels. If taken alongside thyroid hormone replacement therapy like levothyroxine, it may interfere with the intended dosage and efficacy, leading to symptoms of hyperthyroidism or inconsistent thyroid panel results. Patients on thyroid medication should avoid this herb or be monitored closely by a physician. This interaction is supported by pharmacological data and theoretical evidence (Level C).
What is the recommended dosage for Commiphora wightii extract?
The standard adult dosage for Commiphora wightii is typically 500 mg to 1 gram of standardized guggulipid extract taken two to three times daily. This extract should be standardized to contain approximately 2.5% to 5% guggulsterones to ensure therapeutic potency. Because the raw resin can cause digestive upset, standardized extracts are preferred over crude gum preparations. Clinical studies investigating cholesterol and arthritis have utilized these specific dosage ranges, though individual needs may vary based on the specific health concern.
Is Commiphora wightii safe to take during pregnancy?
No, Commiphora wightii is considered unsafe during pregnancy and breastfeeding. The herb has been traditionally used as an emmenagogue, meaning it can stimulate blood flow in the pelvic area and uterus, which may induce uterine contractions and potentially lead to miscarriage or premature labor. Due to these safety concerns and a lack of teratogenicity data, pregnant women should strictly avoid guggul supplements. This contraindication is supported by both traditional use knowledge and safety classifications.
Is guggul effective for treating arthritis?
Guggul has been used in Ayurvedic medicine for centuries to treat inflammatory joint conditions like arthritis. Preliminary research (Level C) suggests that the guggulsterones in the resin possess anti-inflammatory properties that may help reduce joint pain and swelling, comparable to some non-steroidal anti-inflammatory drugs (NSAIDs). However, clinical trial data is limited and sometimes conflicting regarding its efficacy compared to standard treatments. While some patients report relief, individuals with arthritis should consult a rheumatologist before substituting conventional care with herbal remedies.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Commiphora wightii, commonly known as guggul, is a tree whose oleo-gum resin is used in traditional Ayurvedic, Siddha, and Unani medicine for treating obesity, inflammation, and lipid disorders [PMID:29746995, PMID:26587309].
Background
Commiphora wightii (syn. Commiphora mukul) is a plant native to the dry regions of India (specifically Gujarat, Rajasthan, and Madhya Pradesh) and bordering regions of Pakistan [PMID:26587309, PMID:23716870]. The medicinal part is an oleo-gum resin tapped from incisions made in the bark [PMID:26587309].
Traditional uses
Traditionally used in Ayurveda for centuries to treat obesity, liver disorders, internal tumors, malignant sores, ulcers, urinary complaints, intestinal worms, leucoderma, sinus, edema, sudden paralytic seizures, inflammation, gout, and rheumatism [PMID:26561056, PMID:26587309, PMID:27771932].
Active compounds
The primary bioactive constituents are the plant sterol isomers E- and Z-guggulsterone [PMID:12626688, PMID:32110820]. Other identified metabolites include amino acids, fatty acids, organic acids, phenolic acids, pregnane-derivatives, steroids, sterols, sugars, sugar alcohols, terpenoids, tocopherol, quinic acid, and myo-inositol [PMID:25561401, PMID:26587309].
Mechanism of action
Guggulsterones act as antagonist ligands for the farnesoid X receptor (FXR), which regulates bile acid and cholesterol homeostasis [PMID:12626688, PMID:27771932]. They also modulate gene expression by regulating transcription factors such as NF-kappaB, STAT-3, and C/EBPalpha, and downregulating anti-apoptotic proteins (e.g., Bcl-2, survivin) and cell cycle proteins (cyclin D1, c-Myc) [PMID:26561056, PMID:27771932, PMID:19189646].
Clinical evidence
Evidence AHyperlipidemia
Systematic review and other studies indicate significant decreases in total cholesterol and LDL cholesterol [PMID:20858178, PMID:16338199], although some data in Western populations show modest or inconsistent results [PMID:19114224, PMID:37300664].
Evidence CCancer/Tumors
Guggulsterone inhibits the growth of various tumor cells, induces apoptosis, and suppresses osteosarcoma progression by inhibiting glycolysis via the MAPK signaling pathway [PMID:26561056, PMID:40517691].
Evidence CInflammation/Arthritis
Used for treating inflammation, rheumatism, and joint disorders [PMID:32110820, PMID:26587309].
Evidence summary
The evidence for lipid-lowering effects is supported by systematic reviews and clinical trials, though results vary by population. Anti-cancer and anti-inflammatory claims are largely supported by in vitro, animal models, and review articles.
PubMed sources
1.PMID: 29746995 (2018) — Rising trade, declining stocks: The global gugul (Commiphora wightii) trade. · Journal of ethnopharmacology
2.PMID: 26561056 (2016) — Guggulsterone for Chemoprevention of Cancer. · Current pharmaceutical design
3.PMID: 25561401 (2015) — Metabolic profiling of Commiphora wightii (guggul) reveals a potential source for pharmaceuticals and nutraceuticals. · Phytochemistry
4.PMID: 12626688 (2003) — GUGULIPID: a natural cholesterol-lowering agent. · Annual review of nutrition
5.PMID: 18078436 (2007) — Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits. · Cardiovascular drug reviews
6.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
PMID: 32110820 (2020) — Guggulipid: A Promising Multi-Purpose Herbal Medicinal Agent. · Drug research
7.PMID: 16338199 (2005) — Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration. · Complementary therapies in medicine
8.PMID: 19114224 (2009) — Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study. · Complementary therapies in medicine
9.PMID: 23716870 (2012) — Comparative Study of Hypolipidemic Profile of Resinoids of Commiphora mukul/Commiphora wightii from Different Geographical Locations. · Indian journal of pharmaceutical sciences
10.PMID: 40517691 (2025) — Guggulsterone suppresses osteosarcoma progression by inhibiting glycolysis through MAPK signaling pathway. · Phytomedicine : international journal of phytotherapy and phytopharmacology
11.PMID: 27771932 (2016) — Guggulsterone and Its Role in Chronic Diseases. · Advances in experimental medicine and biology
13.PMID: 26587309 (2015) — Pharmacology and Phytochemistry of Oleo-Gum Resin of Commiphora wightii (Guggulu). · Scientifica
14.PMID: 26664894 (2015) — Role of Nutraceuticals in Hypolipidemic Therapy. · Frontiers in cardiovascular medicine
15.PMID: 37300664 (2023) — Supplements for Lipid Lowering: What Does the Evidence Show? · Current cardiology reports
16.PMID: 20858178 (2010) — The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review. · Current pharmaceutical design
17.PMID: 37196815 (2023) — Protective effect of oleo-gum resin of Commiphora wightii against elastase-induced chronic obstructive pulmonary disease-linked lung inflammation and emphysema: Isolation and identification of key bioactive phytoconstituent. · Journal of ethnopharmacology
18.PMID: 35152549 (2022) — Standardization and validation of phytometabolites by UHPLC and high-performance thin layer chromatography for rapid quality assessment of ancient ayurvedic medicine, Mahayograj Guggul. · Journal of separation science
19.PMID: 19189646 (2008) — The guggul for chronic diseases: ancient medicine, modern targets. · Anticancer research